MENU
AVIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Atea Pharmaceuticals (AVIR) Ownership - Who owns Atea Pharmaceuticals?
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
253.15M
P/E Ratio
N/A
Total Cash
454.72M
Projected Growth
N/A
Total Debt
1.64M
Revenue
N/A
Risk (Beta)
0.69
Dividend Yield
N/A
Total Cash/Share
5.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVIR
Capitalization
253M
P/E Ratio
N/A
Risk (Beta)
0.69
Dividend Yield
N/A
Total Cash
455M
Total Cash/Share
5.32
Total Debt
1.64M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
439M
P/B Ratio
0.58
Cash Flow
N/A
Earnings
-2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
84K
Current Ratio
24.85
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-192.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.78
Shares Held By Institutions
280M
Shares Outstanding - Current
85.5M
Total Liabilities
25.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-13.731
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of vaccines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com